Minister for Health Sussan Ley
has approved Genzyme’s Myozyme
(alglucosidase alfa) for patients over
18 with late-onset Pompe disease
through the Life Saving Drugs
Programme (LSDP) from 01 Sep.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 28 Jul 15 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Jul 15
SIGMA Healthcare ceo Mark Hooper yesterday confirmed the company was “starting to see a return to growth in our brand member pipeline,” but said general trading conditions have continued to be challenging in the last quarter.